VNS in drug resistant epilepsy: preliminary report on a small group of patients
<p>Abstract</p> <p>Background</p> <p>In 1997 Vagus Nerve Stimulation (VNS) received approval from the US Food and Drug Administration (FDA) as an adjunctive therapy in the treatment of medically intractable partial epilepsy in people aged 12 years and older who are inel...
Main Authors: | Iero Luisa, Cecconi Ilaria, Brunetto Daniela, Colonnelli Maria, Gentile Valentina, Franzoni Emilio, Moscano Filomena C, Cordelli Duccio M, Marchiani Valentina |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-04-01
|
Series: | Italian Journal of Pediatrics |
Online Access: | http://www.ijponline.net/content/36/1/30 |
Similar Items
-
VNS parameters for clinical response in Epilepsy
by: Firas Fahoum, et al.
Published: (2022-05-01) -
VNS - second chance for a patient after failed epilepsy surgery
by: I. Trifonov, et al.
Published: (2022-01-01) -
Feasibility study of microburst VNS therapy in drug-resistant focal and generalized epilepsy
by: Cornelia Drees, et al.
Published: (2024-03-01) -
Vagus Nerve Stimulation (VNS) Therapy System in pharmacoresistant epilepsy: A literature review
by: Moroșanu Valentin, et al.
Published: (2023-09-01) -
Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug‐resistant epilepsy enrolled in a Russian VNS Registry
by: Anna A. Feygina, et al.
Published: (2023-07-01)